ESG

A new public-private partnership in Sweden aims to revolutionize EV batteries with high-density, sustainable graphite-silicon anodes.

A new self-serve platform offers on-demand NVIDIA and AMD systems locally, providing an alternative to cloud costs and lock-in for AI and VFX industries.

A Korean firm says it can cure 34 diseases using cells from cloned embryos, walking a fine line between a medical breakthrough and a bioethical taboo.

ZEISS launches Collaborative Care, a cloud-based solution to connect optometrists and ophthalmologists, streamlining referrals and data sharing for better care.

With the launch of Steelforce America, the global steel firm appoints a new CEO to capture growth in a dynamic, multi-billion dollar market.

How a unique Japanese hospitality philosophy helped Japan House London beat 1,600 rivals to be crowned the best visitor experience in the UK's cultural sector.

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

With a record 8 million kg of batteries collected in 2025, Canada is winning its fight against waste. See how local efforts are paving the way for an EV future.

With its stock under pressure, Geron will face investors to defend its RYTELO sales strategy and address delays in its pivotal myelofibrosis trial.

New federal initiatives are fast-tracking deep brain stimulation research, a move championed by Nexalin Technology that could revolutionize care for veterans.

America's power grid is at a breaking point. A new report reveals how homeowners and smart tech are forging a resilient, decentralized energy future.

BioVie faces a pivotal moment, touting breakthrough drugs for Alzheimer's and cirrhosis while navigating clinical setbacks and financial pressures.

At a key industry summit, Sutro Biopharma showcases its next-gen ADC platform, designed to overcome treatment resistance with "supercharged" dual-payload drugs.

As Lyell presents at three major investor conferences, the biotech's pipeline, financial health, and future in cancer therapy are under scrutiny.

A Malaysian biotech's new study shows its NK cell therapy is safe, using a novel, low-cost method that could make advanced cancer treatment affordable worldwide.

Insulation giant PrimaLoft taps a BOA Technology veteran as its new president, signaling a strategic push for commercial growth in the sustainable materials sector.

An international initiative uniting a Japanese firm, the UN, and Aikido masters empowers Los Angeles women with non-violent self-defense techniques.

ITF Therapeutics will unveil 10 new data presentations on its Duchenne therapy, DUVYZAT, offering critical new insights on long-term safety and efficacy.

The Biocodex Microbiota Foundation opens its 10th annual grant, committing a total of half a million dollars to shape the future of U.S. gut health science.

With its lead CAR-T therapy, Descartes-08, in late-stage trials, Cartesian Therapeutics is set to update investors on its pioneering work in autoimmune disease.